Bioanalytical Services Market to Reach US$12.34 Billion by 2031, Driven by Drug Development, Infectious Disease Research, and Outsourced R&D
The global bioanalytical services market is entering a period of strong expansion as pharmaceutical and biotechnology companies increase investments in drug discovery, clinical research, vaccine development, and advanced testing. Bioanalytical services encompass pre-clinical testing, biological fluid and specimen analysis, clinical sample testing, drug metabolite analysis, biomarker evaluation,...
0 Comments 0 Shares 6 Views 0 Reviews